Data security risk Lash Group/ Cencora recently faced a class action settlement related to a February 2024 data breach. This signals a heightened focus on data governance, patient privacy, and security controls—a sales opportunity for enhanced privacy compliance services, breach remediation support, and ongoing security monitoring offerings.
Rapid headcount growth The company announced a substantial increase in employees (2,200). This scale-up suggests growing demand for onboarding, training, and workforce management solutions, as well as scalable patient support infrastructure and HR tech integrations.
Healthcare tech partnerships Historical and ongoing partnerships with Veradigm, Infinitus, Medisafe, AllazoHealth, and others indicate a readiness to adopt digital tools for patient engagement, automation, and analytics. This presents cross-sell opportunities for AI-powered engagement platforms, digital assistant tech, and data-driven care coordination solutions.
Global reach & revenue As a global player within a Fortune-ranked parent with revenue in the multi-billion range, Lash Group serves diverse markets and large pharmaceutical customers. This creates opportunity for enterprise-grade solutions, regional deployments, and compliance-ready platforms that scale across geographies.
Innovation legacy Recognition for innovative eBV solutions and ongoing tech stack investments show a culture of modernization and efficiency. Sales could emphasize next-generation automation, cloud-based analytics, and integration capabilities with existing pharma workflows to accelerate market access and patient support.